Oncolytics BiotechONCY

13F holders, Q3 2025 (September 30)
56holders +1
9new positions
8sold out
1famous investor
$1.34avg. 13F price*

At the end of Q3 2025, 56 institutions reported holding Oncolytics Biotech Inc. (ONCY) in their 13F filings, up 1 from Q2 2025. 9 opened new positions and 8 sold out. The largest holders were Morgan Stanley ($537K), Citadel Advisors ($535K) and Marshall Wace, LLP ($454K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Oncolytics Biotech Inc.
CUSIP
682310875
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q1 2024: 36Q1 2024Q2 2024: 41Q2 2024Q3 2024: 42Q3 2024Q4 2024: 46Q4 2024Q1 2025: 51Q1 2025Q2 2025: 55Q2 2025Q3 2025: 56Q3 2025Q4 2025: 61Q4 2025Q1 2026: 57Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions9$1.3M
Exits8$55K

All 13F filers, Q2 2025 → Q3 2025: 1,446,736 shares bought and 122,415 shares sold, net +1,324,321 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 56 holders

Morgan Stanley 0.00% Add +1933.3% 383,346 $537K
Citadel Advisors 0.00% New 382,051 $535K
Marshall Wace, LLP 0.00% New 323,982 $454K
Seeds Investor LLC 0.08% Add +15.4% 258,306 $362K
Goldman Sachs Group Inc. 0.00% Add +60.3% 208,698 $292K
International Assets Investment Management, LLC 0.01% No change 206,900 $155K
Quadrature Capital Ltd 0.00% New 106,076 $146K
Royal Bank of Canada 0.00% Add +16.6% 68,233 $96K
Geode Capital Management, LLC 0.00% No change 66,939 $94K
Cibc World Market Inc. 0.00% No change 60,381 $85K
LPL Financial LLC 0.00% New 51,355 $72K
Franklin Resources Inc. 0.00% Add +10.4% 69,842 $71K
Headinvest, LLC 0.01% Reduce -0.3% 44,700 $63K
Badgley Phelps Wealth Managers, LLC 0.00% No change 40,000 $56K
Bank of Montreal 0.00% Reduce -1.4% 38,211 $53K
Ball & Co Wealth Management Inc. 0.04% Add +5.4% 38,253 $53K
Federation des caisses Desjardins du Quebec 0.00% Reduce -10.9% 31,899 $45K
Vantage Point Financial LLC 0.02% No change 29,744 $42K
SeaCrest Wealth Management, LLC 0.00% No change 32,000 $41K
Brave Asset Management Inc. 0.01% No change 25,000 $35K
Cambridge Investment Research Advisors, Inc. 0.00% Add +119.8% 24,771 $35K
Commonwealth Equity Services, LLC 0.00% Reduce -61.4% 25,114 $35K
National Bank of Canada 0.00% Reduce -0.5% 24,542 $34K
UBS Group AG 0.00% Add +10.1% 22,896 $32K
Rockefeller Capital Management L.P. 0.00% New 20,939 $29K
Rovin Capital /Ut/ 0.01% No change 20,620 $29K
PFG Investments, LLC 0.00% Add +47.2% 20,500 $29K
Professional Advisory Services Inc. 0.00% No change 20,000 $28K
HRT Financial LP 0.00% New 19,783 $27K
Scientech Research LLC 0.01% New 18,204 $25K
PNC Financial Services Group, Inc. 0.00% No change 15,055 $21K
Jane Street Group, LLC 0.00% No change 20,330 $21K
Creative Planning 0.00% No change 13,330 $19K
SPC Financial, Inc. 0.00% Add +25.0% 12,500 $18K
Ausdal Financial Partners, Inc. 0.00% No change 12,000 $17K
Kingsview Wealth Management, LLC 0.00% No change 11,210 $16K
Cerity Partners LLC 0.00% No change 10,000 $14K
Allworth Financial LP 0.00% No change 8,452 $12K
Valley National Advisers Inc. 0.00% No change 7,000 $9K
Cedar Mountain Advisors, LLC 0.00% No change 5,651 $8K
Activest Wealth Management 0.00% No change 5,000 $7K
Wells Fargo & Company 0.00% No change 4,401 $6K
BlackRock, Inc. 0.00% No change 3,000 $4K
BNP Paribas Financial Markets 0.00% New 2,884 $4K
Jones Financial Companies LLLP 0.00% No change 2,053 $3K
Cwm, LLC 0.00% No change 1,325 $2K
Bank of America Corp. 0.00% New 1,000 $1K
MAI Capital Management 0.00% No change 526 $737
TD Waterhouse Canada Inc. 0.00% No change 400 $562
JNBA Financial Advisors 0.00% No change 210 $294
Sound Income Strategies, LLC 0.00% No change 194 $241
Dogwood Wealth Management LLC 0.00% No change 146 $204
IFP Advisors, Inc 0.00% No change 100 $140
Osaic Holdings, Inc. 0.00% Reduce -99.1% 63 $88
Aviso Financial Inc. 0.00% No change 52 $72
Wolff Wiese Magana LLC 0.00% Reduce -24.4% 31 $44

"% of holder's portfolio" is ONCY's weight in each manager's 13F, not the share of Oncolytics Biotech Inc. the manager owns.